Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEIC: adMSC for Crohn's Disease Stenosis
NCT05521672Phase 2Terminated
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Adipose-derived allogeneic mesenchymal stem cells (IIS-FJD) in Crohn's disease, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Started Oct 2022; status: terminated.
02
Drugs
Adipose-derived allogeneic mesenchymal stem cells (IIS-FJD)
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT05521672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05521672.